• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Illumina

Illumina

Illumina Inc ILMN 3 Star

Last Price$179.08Day Change (%)-0.48%
Open Price$179.82Day Change ($)-0.86
Day Range178.03–180.1552-Week Range72.77–185.00

As of Thu 08/28/2014 03:42 PM EST | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology

    Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology

  2. Research and Markets: The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition (2014)

    Research and Markets: The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition (2014)

  3. Roche to buy InterMune for $8.3 billion

    Roche to buy InterMune for $8.3 billion

  4. A Shift in Health-Care M&A Activity

    Recent deals have been driven more by tax strategies than therapeutic synergies.

  5. Research and Markets: Molecular Biology Enzymes, Kits, & Reagents Market by Application, Product - Global Forecast to 2018

    Research and Markets: Molecular Biology Enzymes, Kits, & Reagents Market by Application, Product - Global Forecast to 2018

  6. Research and Markets: Global Biomarkers Markets Report 2014-2018: Cancer, Cardiac, Blood, Endocrine & Infectious Disease and Neurological Disease Markers

    Research and Markets: Global Biomarkers Markets Report 2014-2018: Cancer, Cardiac, Blood, Endocrine & Infectious Disease and Neurological Disease Markers

  7. Research and Markets: Global Human Identification Market Report 2014-2018: Technology, Application, DNA Amplification, Quantification, Extraction, Services, & Software Analysis

    Research and Markets: Global Human Identification Market Report 2014-2018: Technology, Application, DNA Amplification, Quantification, Extraction, Services, & Software Analysis

  8. UK to Become World Number One in DNA Testing with Plan to Revolutionise Fight Against Cancer and Rare Diseases

    UK to Become World Number One in DNA Testing with Plan to Revolutionise Fight Against Cancer and Rare Diseases

  9. UPDATE: S&P 500, Nasdaq retest major support -4-

    UPDATE: S&P 500, Nasdaq retest major support -4-

  10. UPDATE: S&P 500, Nasdaq retest major support -8-

    UPDATE: S&P 500, Nasdaq retest major support -8-

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.